Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Clinical Study Testing The Safety And Efficacy Of Crizotinib In East Asian Patients With Anaplastic Lymphoma Kinase (ALK) Positive Advanced Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging
- Status
- TERMINATED
- Phase
- N/A
Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose
- Status
- COMPLETED
- Phase
- PHASE4
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Feasibility Study of Oral Adjuvant Chemotherapy With S-1
- Status
- COMPLETED
- Phase
- PHASE2
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
- Status
- UNKNOWN
- Phase
- N/A
Zalutumumab in Non-Small Cell Lung Cancer (NSCLC) Patients Refractory to Tyrosine Kinase Inhibitors
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2